Tenshi Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2,072.90 Cr
as on 17-06-2024
- Paid Up Capital ₹ 443.43 Cr
as on 17-06-2024
- Company Age 8 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1,337.40 Cr
as on 17-06-2024
- Satisfied Charges ₹ 52.00 Cr
as on 17-06-2024
- Revenue 22.83%
(FY 2023)
- Profit -235.97%
(FY 2023)
- Ebitda 47.19%
(FY 2023)
- Net Worth -37.60%
(FY 2023)
- Total Assets 0.39%
(FY 2023)
About Tenshi Pharmaceuticals
The Corporate was formerly known as Sovizen Life Sciences Private Limited. The Company is engaged in the Financial Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2,072.90 Cr and a paid-up capital of Rs 443.43 Cr.
The company currently has active open charges totaling ₹1,337.40 Cr. The company has closed loans amounting to ₹52.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Tenshi Pharmaceuticals Private Limited India is Pooja Kumar as COMPANY SECRETARY. Raju Ravishankar and Chandrappa Seetharamaiah serve as directors at the Company.
- CIN/LLPIN
U74999TN2016PTC128331
- Company No.
128331
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Jul 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai City Corporation, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Tenshi Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pooja Kumar  | Company Secretary | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Raju Ravishankar | Additional Director | Current | |
| Chandrappa Seetharamaiah | Director | 31-Jul-2018 | Current |
Financial Performance and Corporate Structure Insights of Tenshi Pharmaceuticals.
Tenshi Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 22.83% increase. The company also saw a substantial fall in profitability, with a 235.97% decrease in profit. The company's net worth observed a substantial decline by a decrease of 37.6%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Tenshi Pharmaceuticals?
In 2023, Tenshi Pharmaceuticals had a promoter holding of 94.09% and a public holding of 5.91%. The company had 4 Subsidiaries, 1 Joint Venture and 5 Associate Companies. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Skanray Healthcare Global Private LimitedActive 11 years 8 monthsChandrappa Seetharamaiah is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 20 Oct 2023 | ₹35.00 Cr | Open |
Others Creation Date: 09 Sep 2023 | ₹50.00 Cr | Open |
Others Creation Date: 17 Aug 2023 | ₹50.00 Cr | Open |
How Many Employees Work at Tenshi Pharmaceuticals?
Tenshi Pharmaceuticals has a workforce of 8 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Tenshi Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tenshi Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
